• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[In-patient nuclear medicine therapy in Germany from 2010 to 2012. Analysis of structured quality reports].

作者信息

Lorenz R, Buck A, Reiners C

机构信息

Dr. Reinhard Lorenz, Klinik und Poliklinik für Nuklearmedizin, Universität Würzburg, Universitätsklinikum Haus A4, Oberdürrbacher Str. 6, 97080 Würzburg, Tel. 09 31/20 13 59 32, Fax 09 31/20 15 56 88, E-Mail:

出版信息

Nuklearmedizin. 2015;54(2):61-8. doi: 10.3413/Nukmed-0725-15-02. Epub 2015 Feb 27.

DOI:10.3413/Nukmed-0725-15-02
PMID:25720461
Abstract

UNLABELLED

The aim of this analysis was to collect and analyse Germany-wide data on the status and development of in-patient Nuclear Medicine therapy. The official hospital quality reports were to be used as the data source.

METHODS

The reference reports from all hospitals in Germany with Nuclear Medicine therapy units, compiled by Gemeinsamer Bundesausschuss (G-BA) from the machine-usable XML data of the quality reports, were analysed for the years 2010 and 2012. Results from our own preceding investigations of structured quality reports for the years 2004, 2006 and 2008 were used to assess the longer-term development. To determine the Germany-wide incidence of thyroid surgery and radio-iodine therapy, public databases of Institut für das Entgeltsystem im Krankenhaus (InEK) were assessed for the years from 2004 to 2012.

RESULTS

The total number of in-patient Nuclear Medicine treatment cases decreased from 50 363 to 47 314 patients in the period from 2010 to 2012. There was a marked decline of 17.5% in case incidence over the longer period from 2004 to 2012. The decrease is primarily due to a decrease in cases with hyperthyroidism (ICD code E05). The number of thyroid surgeries has been declining since 2009. There was a moderate 23.7% increase in the number of cases with the diagnosis of thyroid carcinoma (ICD code C73) from 2004 to 2012.

CONCLUSIONS

Presumably, the improved iodine supply in Germany has led to a decline in inpatients with hyperthyroidism in nuclear medicine and consequently to a decrease in both the number of radio-iodine therapies and thyroid operations in surgery. In contrast, the number of patients in nuclear medicine therapy units diagnosed with thyroid cancer has increased moderately which correlates with the worldwide increasing incidence of this disease.

摘要

相似文献

1
[In-patient nuclear medicine therapy in Germany from 2010 to 2012. Analysis of structured quality reports].
Nuklearmedizin. 2015;54(2):61-8. doi: 10.3413/Nukmed-0725-15-02. Epub 2015 Feb 27.
2
[Nuclear medical inpatient treatment in Germany - analysis of structured quality reports 2004-2008].[德国核医学住院治疗——2004 - 2008年结构化质量报告分析]
Nuklearmedizin. 2010;49(2):49-57. doi: 10.3413/nukmed-0296. Epub 2010 Mar 1.
3
[Nuclear Medicine in Germany. Updated key data and trends from official statistics].
Nuklearmedizin. 2017 Apr 5;56(2):55-68. doi: 10.3413/Nukmed-0880-17-02. Epub 2017 Mar 7.
4
[Nuclear Medicine in Germany. Key data from official statistics].[德国的核医学。官方统计的关键数据]
Nuklearmedizin. 2011;50(2):53-67. doi: 10.3413/Nukmed-0380-11-01.
5
[Radioiodine therapy for benign thyroid diseases (version 5). German Guideline].[良性甲状腺疾病的放射性碘治疗(第5版)。德国指南]
Nuklearmedizin. 2016 Dec 6;55(6):213-220. doi: 10.3413/Nukmed-0823-16-04.
6
Radioprotection using iodine-131 for thyroid cancer and hyperthyroidism: a review.使用碘-131对甲状腺癌和甲状腺功能亢进症进行辐射防护:综述
Clin J Oncol Nurs. 2008 Dec;12(6):905-12. doi: 10.1188/08.CJON.905-912.
7
Effects of Adequate Iodine Supply on the Incidence of Iodine-Induced Thyroid Disorders in Slovenia.充足碘供应对斯洛文尼亚碘致甲状腺疾病发病率的影响。
Thyroid. 2017 Apr;27(4):558-566. doi: 10.1089/thy.2016.0186. Epub 2017 Feb 1.
8
[Thyroid diseases in sub-Saharan Africa].[撒哈拉以南非洲地区的甲状腺疾病]
Sante. 2007 Jan-Mar;17(1):33-9.
9
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4].[分化型甲状腺癌放射性碘治疗程序指南。第4版]
Nuklearmedizin. 2016 Jun 28;55(3):77-89.
10
[Radioiodine therapy of differentiated thyroid cancer. Recommendations of the Therapy Study Group of the German Society of Nuclear Medicine].[分化型甲状腺癌的放射性碘治疗。德国核医学协会治疗研究组的建议]
Nuklearmedizin. 1992 Aug;31(4):151-3.

引用本文的文献

1
The influence of thionamides on intra-thyroidal uptake of I during radioiodine-131 treatment of Graves' disease.硫脲类药物对 131I 治疗格雷夫斯病时甲状腺内摄取碘的影响。
Sci Rep. 2023 Dec 1;13(1):21190. doi: 10.1038/s41598-023-47228-z.
2
The influence of thyroid hormone medication on intra-therapeutic half-life of I during radioiodine therapy of solitary toxic thyroid nodules.甲状腺激素药物对孤立性毒性甲状腺结节放射性碘治疗期间 I 内治疗半衰期的影响。
Sci Rep. 2022 Aug 17;12(1):13925. doi: 10.1038/s41598-022-18170-3.
3
Thyroid stunning in radioiodine-131 therapy of benign thyroid diseases.
放射性碘-131 治疗良性甲状腺疾病中的甲状腺抑制。
Endocrine. 2019 Mar;63(3):537-544. doi: 10.1007/s12020-018-01833-5. Epub 2018 Dec 31.
4
Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey.分子放射治疗实践与剂量测定实施的差异:一项欧洲调查的结果
EJNMMI Phys. 2017 Dec 4;4(1):28. doi: 10.1186/s40658-017-0193-4.